INETETAMAB

Clinical trials for INETETAMAB explained in plain language.

Never miss a new study

Get alerted when new INETETAMAB trials appear

Sign up with your email to follow new studies for INETETAMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for tough breast cancer cases: experimental combo targets tumors that outsmarted standard therapy

Disease control Recruiting now

This study is testing whether a new two-drug combination (SKB264 plus inetetamab) can help control advanced HER2-positive breast cancer that has continued to grow despite previous treatment with the standard drug T-DXd. The trial will enroll 48 adults whose cancer has spread and …

Matched conditions: INETETAMAB

Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

INETETAMAB

Get alerted when new INETETAMAB trials appear

New hope for tough breast cancer cases: experimental combo targets tumors that outsmarted standard therapy